One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab.
Mueller BU, Bennett CM, Feldman HA, Bussel JB, Abshire TC, Moore TB, Sawaf H, Loh ML, Rogers ZR, Glader BE, McCarthy MC, Mahoney DH, Olson TA, Feig SA, Lorenzana AN, Mentzer WC, Buchanan GR, Neufeld EJ; Pediatric Rituximab/ITP Study Group; Glaser Pediatric Research Network.
Mueller BU, et al. Among authors: buchanan gr.
Pediatr Blood Cancer. 2009 Feb;52(2):259-62. doi: 10.1002/pbc.21757.
Pediatr Blood Cancer. 2009.
PMID: 18937333
Free PMC article.
Clinical Trial.